In support of a therapy-induced altered cell state described earlier involving transcriptome and metabolome changes [33], Obenauf et al. demonstrated an altered and complex network of secreted signals in BRAF, ALK, or EGFR TKI-treated melanoma and lung adenocarcinoma cells [86]. Here, BRAF is linked to melanoma.